416 related articles for article (PubMed ID: 29054369)
1. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.
Wang J; Yeung BZ; Cui M; Peer CJ; Lu Z; Figg WD; Guillaume Wientjes M; Woo S; Au JL
J Control Release; 2017 Dec; 268():147-158. PubMed ID: 29054369
[TBL] [Abstract][Full Text] [Related]
2. A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy.
Wang J; Yeung BZ; Wientjes MG; Cui M; Peer CJ; Lu Z; Figg WD; Woo S; Au JL
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34209265
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
[TBL] [Abstract][Full Text] [Related]
4. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
5. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
6. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
[No Abstract] [Full Text] [Related]
7. Mechanism of recipient cell-dependent differences in exosome uptake.
Horibe S; Tanahashi T; Kawauchi S; Murakami Y; Rikitake Y
BMC Cancer; 2018 Jan; 18(1):47. PubMed ID: 29306323
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell-derived exosome-entrapped paclitaxel can enhance its anti-tumor effect.
Han D; Wang K; Zhang T; Gao GC; Xu H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5703-5713. PubMed ID: 32495906
[TBL] [Abstract][Full Text] [Related]
10. MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis.
Zhang S; Zhong J; Guo D; Zhang S; Huang G; Chen Y; Xu C; Chen W; Zhang Q; Zhao C; Liu S; Luo Z; Lin C
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23380. PubMed ID: 37132394
[TBL] [Abstract][Full Text] [Related]
11. Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance.
Zhang FF; Zhu YF; Zhao QN; Yang DT; Dong YP; Jiang L; Xing WX; Li XY; Xing H; Shi M; Chen Y; Bruce IC; Jin J; Ma X
Eur J Pharmacol; 2014 Sep; 738():83-90. PubMed ID: 24877693
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
Front Immunol; 2021; 12():692654. PubMed ID: 34149737
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques.
Salarpour S; Forootanfar H; Pournamdari M; Ahmadi-Zeidabadi M; Esmaeeli M; Pardakhty A
Daru; 2019 Dec; 27(2):533-539. PubMed ID: 31317441
[TBL] [Abstract][Full Text] [Related]
14. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
[TBL] [Abstract][Full Text] [Related]
15. Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway.
Riches A; Campbell E; Borger E; Powis S
Eur J Cancer; 2014 Mar; 50(5):1025-34. PubMed ID: 24462375
[TBL] [Abstract][Full Text] [Related]
16. Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer.
Kurebayashi J; Nukatsuka M; Sonoo H; Uchida J; Kiniwa M
Cancer Chemother Pharmacol; 2010 Jan; 65(2):219-25. PubMed ID: 19455332
[TBL] [Abstract][Full Text] [Related]
17. Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells.
Guay C; Menoud V; Rome S; Regazzi R
Cell Commun Signal; 2015 Mar; 13():17. PubMed ID: 25880779
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin Expands in Vivo Secretion of Circulating Exosome in Mice.
Emam SE; Ando H; Abu Lila AS; Kobayashi S; Shimizu T; Okuhira K; Ishima Y; Ishida T
Biol Pharm Bull; 2018; 41(7):1078-1083. PubMed ID: 29962402
[TBL] [Abstract][Full Text] [Related]
20. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
Li J; JunYu ; Liu A; Wang Y
Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]